Clinical trials
Phase 1/2 Lymphoma trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
55 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2014 | 2 |
| 2015 | 2 |
| 2016 | 5 |
| 2017 | 4 |
| 2018 | 2 |
| 2019 | 2 |
| 2020 | 3 |
| 2021 | 6 |
| 2022 | 8 |
| 2023 | 4 |
| 2024 | 6 |
| 2025 | 8 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 30 |
| Recruiting | 16 |
| Completed | 4 |
| Withdrawn | 2 |
| Suspended | 1 |
| Active, not recruiting | 1 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Chinese PLA General Hospital | 5 |
| Southwest Hospital, China | 5 |
| Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | 3 |
| 920th Hospital of Joint Logistics Support Force of People's Liberation Army of China | 2 |
| Affiliated Hospital to Academy of Military Medical Sciences | 2 |
| Chongqing Precision Biotech Co., Ltd | 2 |
| Essen Biotech | 2 |
| Zhujiang Hospital | 2 |
| AstraZeneca | 1 |
| Bangdong Gong | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lymphoma | 55 |
| Leukemia | 12 |
| Recurrence | 8 |
| Lymphoma, B-Cell | 7 |
| Leukemia, Myeloid, Acute | 6 |
| Burkitt Lymphoma | 5 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 5 |
| Multiple Myeloma | 5 |
| Leukemia, B-Cell | 4 |
| Lymphoma, Large B-Cell, Diffuse | 4 |
Trials
Showing 1 to 25 of 55. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.